| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.31 | 2e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 6e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |